X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (154) 154
hematology (148) 148
index medicus (129) 129
bypassing agents (124) 124
hemophilia (112) 112
hemophilia a - drug therapy (93) 93
inhibitors (88) 88
male (59) 59
blood coagulation factors - therapeutic use (51) 51
recombinant factor-viia (48) 48
adult (47) 47
haemophilia (47) 47
hemophilia a - immunology (47) 47
feiba (45) 45
prophylaxis (44) 44
inhibitor (43) 43
recombinant factor viia (38) 38
activated factor-vii (37) 37
prothrombin complex concentrate (37) 37
recombinant proteins - therapeutic use (37) 37
adolescent (36) 36
factor viii - immunology (35) 35
peripheral vascular disease (35) 35
factor viia - therapeutic use (34) 34
thrombin (34) 34
young adult (33) 33
child (32) 32
blood coagulation factor viii (30) 30
female (29) 29
immune tolerance induction (29) 29
analysis (28) 28
hemophilia a - complications (28) 28
management (28) 28
thrombin generation (28) 28
factor viii - therapeutic use (27) 27
surgery (27) 27
therapy (27) 27
treatment outcome (27) 27
bypassing agent (26) 26
hemophilia a - blood (26) 26
middle aged (26) 26
care and treatment (25) 25
factor viii (25) 25
hemorrhage - prevention & control (25) 25
factor-ix (23) 23
animals (22) 22
factor-ix inhibitors (22) 22
hemophilia a - therapy (22) 22
immune tolerance (22) 22
haemophilia a (21) 21
bleeding (20) 20
hemorrhage - drug therapy (20) 20
quality-of-life (20) 20
recombinant proteins - administration & dosage (20) 20
aged (19) 19
blood coagulation factor inhibitors - blood (19) 19
child, preschool (19) 19
efficacy (19) 19
home treatment (19) 19
rfviia (19) 19
bleeding episodes (18) 18
prothrombin (18) 18
safety (18) 18
blood coagulation factors (17) 17
blood coagulation factors - administration & dosage (17) 17
bypassing therapy (17) 17
hemophilia a - diagnosis (17) 17
tissue factor (17) 17
factor viia (16) 16
factor viia - administration & dosage (16) 16
factor-viii (16) 16
factor-viii inhibitors (15) 15
hemophilia a (15) 15
hemorrhage - etiology (15) 15
plasma (15) 15
clinical medicine (14) 14
coagulants - therapeutic use (14) 14
diagnosis (14) 14
factor viii inhibitors (14) 14
hemophilia b - drug therapy (14) 14
klinisk medicin (14) 14
medical and health sciences (14) 14
medicin och hälsovetenskap (14) 14
novoseven (14) 14
retrospective studies (14) 14
antibodies (13) 13
coagulation (13) 13
coagulation factors (13) 13
hemophilia-a (13) 13
hemorrhage (13) 13
recombinant activated factor vii (13) 13
apcc (12) 12
factor eight inhibitor bypassing activity (12) 12
hemostasis (12) 12
partial thromboplastin time (12) 12
patients (12) 12
thrombin generation assay (12) 12
thrombin generation test (12) 12
acquired haemophilia (11) 11
blood coagulation - drug effects (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2015, Volume 13, Issue 3, pp. 426 - 436
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2011, Volume 155, Issue 2, pp. 256 - 262
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 08/2012, Volume 10, Issue 8, pp. 1478 - 1485
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 04/2012, Volume 38, Issue 3, pp. 265 - 267
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 08/2019, Volume 35, Issue 8, pp. 1433 - 1440
Objective: To assess real-world costs for patients with hemophilia A treated with bypassing agents versus factor VIII (FVIII) replacement. Methods: Claims data... 
bypassing agents | FVII replacement | Hemophilia A | healthcare costs | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | COMORBIDITIES | INHIBITORS | RESOURCE UTILIZATION
Journal Article
Best Practice & Research: Clinical Anaesthesiology, ISSN 1521-6896, 2013, Volume 27, Issue 1, pp. 141 - 160
The transfusion of allogeneic blood products has been considered as a life-saving procedure for patients suffering from major traumatic injury and those who... 
Anesthesia & Perioperative Care | fresh-frozen plasma | factor XIII concentrate | prothrombin complex concentrate | factor VIII-bypassing agent | solvent–detergent plasma | recombinant activated factor VII | fibrinogen concentrate | solvent-detergent plasma
Journal Article
Journal Article
Blood Research, ISSN 2287-979X, 09/2015, Volume 50, Issue 3, pp. 173 - 178
Inhibitory antibodies to factor VIII (FVIII) or IX (FIX) are important issues when managing patients with hemophilia A or B. Advances in bypassing agents such... 
inhibitor | Bypassing agent | Hemophilia | surgery | Inhibitor | Surgery | Original
Journal Article
Journal Article